In a recent Science article, researchers unveiled a method to kill cancer cells by sticking two proteins together to activate a gene that signals for cell death. This new method is helpful for ...

A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...

Researchers at the University of Texas at Austin have pioneered an innovative technique that uses LED light and tin nanoflakes to selectively destroy cancer cells while sparing healthy tissue. This ...

Engineered bacteria reprogram tumor macrophages and direct copper into cancer cells, triggering cell death and systemic immunity without damaging healthy tissue. (Nanowerk Spotlight) Tumors do not ...

Researchers have created tiny metal-based particles that push cancer cells over the edge while leaving healthy cells mostly unharmed. The particles work by increasing internal stress in cancer cells ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their cancer. One of the limitations of CAR-T cell ...

As part of a study published in January, 37 people who had been through various failed treatments for blood cancer received infusions of genetically enhanced immune cells that researchers hoped would ...

Lipid nanoparticles without drugs can make some cancer cells swell and burst, offering a new way to target tumors resistant to existing treatments. (Nanowerk Spotlight) The ability to selectively ...

Jonathan Fisher works for University College London and is an inventor on patents pertaining to gamma-delta T cell immunotherapy. In the past 5 years he has received research funding from UKRI, the ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of Medicine, ...